| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
See Remarks | President And CEO
1 company
Watanabe Todd is a See Remarks at Arcutis Biotherapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 10 sells.
Estimated insider holdings value: $20.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 5, 2021 | ARQT Arcutis Biotherapeutics, Inc. | President And CEO | Sale+OE | 2,500 | $24.92 | $62,293.50 | -0.4% | -10.6% | -21.8% | |
| Oct 1, 2021 | ARQT Arcutis Biotherapeutics, Inc. | President And CEO | Sale+OE | 1,500 | $25.01 | $37,510.05 | -0.3% | -18.8% | -24.2% | |
| Sep 7, 2021 | ARQT Arcutis Biotherapeutics, Inc. | President And CEO | Sale+OE | 1,000 | $21.14 | $21,137.00 | -0.2% | -24.6% | +4.6% | |
| Aug 5, 2021 | ARQT Arcutis Biotherapeutics, Inc. | President And CEO | Sale+OE | 1,000 | $20.81 | $20,810.00 | -0.2% | +9.3% | +15.2% | |
| Jul 6, 2021 | ARQT Arcutis Biotherapeutics, Inc. | President And CEO | Sale+OE | 1,750 | $26.58 | $46,515.00 | -0.3% | -1.9% | -10.5% | |
| Jun 7, 2021 | ARQT Arcutis Biotherapeutics, Inc. | President And CEO | Sale+OE | 1,750 | $26.35 | $46,112.50 | -0.3% | -26.0% | -23.1% | |
| May 7, 2021 | ARQT Arcutis Biotherapeutics, Inc. | President And CEO | Sale+OE | 750 | $35.00 | $26,250.00 | -0.1% | -36.0% | -43.2% | |
| May 5, 2021 | ARQT Arcutis Biotherapeutics, Inc. | President And CEO | Sale+OE | 1,750 | $34.00 | $59,500.00 | -0.3% | -32.0% | -37.4% | |
| Apr 30, 2021 | ARQT Arcutis Biotherapeutics, Inc. | President And CEO | Sell | 1,500 | $35.00 | $52,500.00 | -0.3% | -29.4% | -39.7% | |
| Apr 5, 2021 | ARQT Arcutis Biotherapeutics, Inc. | President And CEO | Sell | 1,750 | $29.93 | $52,377.50 | -0.3% | -8.4% | -24.6% |